Fennec Pharmaceuticals (FENC) Gross Margin: 2011-2025
Historic Gross Margin for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to 58.19%.
- Fennec Pharmaceuticals' Gross Margin rose 2417.00% to 58.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.58%, marking a year-over-year decrease of 1169.00%. This contributed to the annual value of 61.24% for FY2024, which is 3284.00% down from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Gross Margin stood at 58.19%, which was up 6.02% from 54.89% recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year Gross Margin high stood at 100.00% for Q1 2021, and its period low was 34.03% during Q3 2024.
- In the last 3 years, Fennec Pharmaceuticals' Gross Margin had a median value of 66.32% in 2025 and averaged 68.78%.
- As far as peak fluctuations go, Fennec Pharmaceuticals' Gross Margin crashed by 6,089bps in 2024, and later surged by 2,417bps in 2025.
- Fennec Pharmaceuticals' Gross Margin (Quarterly) stood at 100.00% in 2021, then remained steady at 100.00% in 2022, then crashed by 704bps to 92.96% in 2023, then tumbled by 4,273bps to 50.23% in 2024, then surged by 2,417bps to 58.19% in 2025.
- Its Gross Margin was 58.19% in Q3 2025, compared to 54.89% in Q2 2025 and 66.32% in Q1 2025.